TMDX - SHAREHOLDER ALERT: TransMedics Group Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm | Benzinga
BOSTON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating TransMedics Group, Inc. (NASDAQ:TMDX) for potential securities law violations. Investors who have lost money in their TransMedics Group investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/tmdx.
What is this all about?
TransMedics shares fell more than 9% on Monday, February 26, after Canaccord Genuity issued a note flagging "potential risk" to the company following receipt of a letter from Representative Paul Gosar accusing the company of, among other things, misappropriating corporate resources, and a Washington Post report regarding a federal investigation of organ transplant organizations. TransMedics developed the FDA-approved Organ Care System.
Who is eligible?
Anyone who purchased TransMedics Group, ...